Motilal Oswal: Covid-19 Led Weakness In GSK Pharma’s Performance In Q1
A GlaxoSmithKline Plc logo sits on glass windows at the company’s headquarters in London, U.K. (Photographer: Simon Dawson/Bloomberg)

Motilal Oswal: Covid-19 Led Weakness In GSK Pharma’s Performance In Q1

Bookmark
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportun...